Developing the basis for an quality control platform for human pluripotent stem cells and their differentiated derivatives

  • McNaughton, Donald (Primary Chief Investigator (PCI))
  • Elefanty, Andrew (Chief Investigator (CI))
  • Stanley, Edouard (Chief Investigator (CI))
  • Tobin, Mark (Partner Investigator (PI))

Project: Research

Project Details

Project Description

We will obtain spectroscopic fingerprints for well characterized differentiated human embryonic stem cells
and develop a platform technology to reliably predict cell phenotype. The technique will then be explored to
determine its capability as a cell selection tool. The research promises to provide a system that will provide
information crucial in developing stem cell technologies for tissue engineering and regenerative medicine.
Hence it will be beneficial in new technologies in the health area with the potential to significantly reduce the
health budget.
Effective start/end date4/01/111/07/14


  • Australian Research Council (ARC): A$310,000.00
  • Monash University